ammonia n-13 Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: [13NH3]
  • InChIKey: QGZKDVFQNNGYKY-BJUDXGSMSA-N
  • Mol. Mass: 16.03
  • ALogP: 0.16
  • ChEMBL Molecule:
    ammonia n 13  
More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

(13n)ammonia | 13n-ammonia | ammonia (13n) | ammonia n 13 | ammonia n-13 | n-13 ammonia | n13 ammonia | nitrogen-13 ammonia

Organizations (43)

Research & Development (13)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (32)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (1)


 

Diagnostic Imaging (approved 2007)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Anemia, Sickle Cell (Phase 2)

Coronary Artery Disease (Phase 2)

Heart Diseases (Phase 4)

Hypertension, Pulmonary (Phase 2)

Pharmacological and Toxicological Phenomena (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial Organizations: 13

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue